Haleon plc (NYSE:HLN) Shares Sold by Whittier Trust Co.

Whittier Trust Co. decreased its holdings in Haleon plc (NYSE:HLN) by 73.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,020 shares of the company’s stock after selling 19,014 shares during the period. Whittier Trust Co.’s holdings in Haleon were worth $67,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. FMR LLC lifted its stake in shares of Haleon by 5.8% in the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after purchasing an additional 5,768,117 shares during the last quarter. Wellington Management Group LLP boosted its stake in Haleon by 49.9% during the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock worth $96,833,000 after buying an additional 3,046,841 shares during the period. Douglas Lane & Associates LLC increased its position in shares of Haleon by 1.9% during the fourth quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock valued at $82,274,000 after acquiring an additional 161,865 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Haleon by 25.3% during the third quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock valued at $53,791,000 after acquiring an additional 1,026,939 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of Haleon in the 4th quarter valued at approximately $42,193,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on HLN. Hsbc Global Res downgraded shares of Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Finally, HSBC reaffirmed a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Haleon presently has an average rating of “Hold” and a consensus target price of $10.95.

Haleon Trading Down 1.4 %

Shares of Haleon stock opened at $10.13 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a fifty day simple moving average of $9.87 and a 200-day simple moving average of $9.88. The stock has a market cap of $45.88 billion, a price-to-earnings ratio of 29.81, a PEG ratio of 2.82 and a beta of 0.25. Haleon plc has a 12-month low of $7.99 and a 12-month high of $10.80.

Haleon (NYSE:HLN) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. On average, equities analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The company also recently declared a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a dividend of $0.1166 per share. This is a positive change from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. Haleon’s payout ratio is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.